The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...
Monthly COVID-19 publications during the Spring 2025 campaign were released from 8 May 2025 to 26 June 2025. The monthly publication for the Spring 2025 campaign includes vaccination information for ...